CINXE.COM

<!DOCTYPE html> <html lang="en"> <head> <meta charset="utf-8"> <meta name="ROBOTS" content="INDEX,FOLLOW"> <meta name="robots" content="noimageindex" /> <title>About us | Worldwide Ophthalmology Training Congress | Telemedicine in Eye Care colloquium | Global Clinical Ophthalmology Meetings |</title> <meta name="keywords" content="About Us, ophthalmology Journals, Article Publication, Manuscript, Quality Control, Review, Conference Organizers, Cancer Complications, Best Oncology Products, Advances in Dry Eye Treatments, Eye Care, Cancer Genetics, Childhood ocular disorder, Cancer Research, Cancer Prevention" /> <meta name="description" content="Connect with Experts and Global Performers at Ophthalmology 2025 conference. Join us for insightful discussions, impactful presentations, and networking opportunities that shape the future of oncology." /> <meta name="author" content="Meetings International"> <link rel="canonical" href="https://www.meetingsint.com/conferences/eye" /> <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta name="citation_publisher" content="Meetings International"/> <meta name="citation_conference_title" content="12th International Conference on Eye and Ophthalmology"> <meta name="citation_year" content="2025"> <meta property="og:title" content="12th International Conference on Eye and Ophthalmology" /> <meta property="og:url" content="https://www.meetingsint.com/conferences/eye" /> <meta property="og:site_name" content="Meetings International" /> <meta property="og:description" content="Connect with Experts and Global Performers at Ophthalmology 2025 conference. Join us for insightful discussions, impactful presentations, and networking opportunities that shape the future of oncology." /> <meta property="og:type" content="website"/> <meta property="og:image:secure_url" content=""> <meta name="twitter:card" content="summary_large_image"> <meta name="twitter:site" content="@MeetingsInt"> <meta name="twitter:creator" content="@MeetingsInt"> <meta name="twitter:title" content="About us | Worldwide Ophthalmology Training Congress | Telemedicine in Eye Care colloquium | Global Clinical Ophthalmology Meetings |"> <meta name="twitter:description" content="Connect with Experts and Global Performers at Ophthalmology 2025 conference. Join us for insightful discussions, impactful presentations, and networking opportunities that shape the future of oncology."> <meta property="twitter:url" content="https://www.meetingsint.com/conferences/eye"> <link rel="icon" href="https://www.meetingsint.com/assets/main/images/favicon.ico"> <link rel="stylesheet" href="https://www.meetingsint.com/assets/conf_web/css/bootstrap.min.css"> <link rel="stylesheet" href="https://www.meetingsint.com/assets/conf_web/css/style.css"> <link rel="stylesheet" href="https://www.meetingsint.com/assets/conf_web/css/responsive.css"> <script async src="https://www.googletagmanager.com/gtag/js?id=G-KD46HN5G7B"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-KD46HN5G7B'); </script> </head> <body id="page-top" data-spy="scroll" data-target=".navbar-fixed-top"> <script src="https://www.meetingsint.com/assets/conf_web/js/jquery.min.js"></script> <header class="main-header"> <div class="main-nav nav-transparent"> <nav class="navbar navbar-default navbar-fixed-top" id="navbar-main"> <div class="no-container"> <div class="navbar-header page-scroll"> <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-ex1-collapse"> <span class="sr-only">Toggle navigation</span> <span class="icon-bar"></span> <span class="icon-bar"></span> <span class="icon-bar"></span> </button> <a class="navbar-brand page-scroll logo-black" title="12th International Conference on Eye and Ophthalmology" href="https://www.meetingsint.com/conferences/eye"><img class="main-logo" src="https://www.meetingsint.com/assets/main/images/meetings-international.png" alt="Logo"> </a> <a class="navbar-brand page-scroll logo-white" title="12th International Conference on Eye and Ophthalmology" href="https://www.meetingsint.com/conferences/eye"><img class="main-logo" src="https://www.meetingsint.com/assets/main/images/meetings-international.png" alt="Logo"> </a> </div> <div class="collapse navbar-collapse navbar-ex1-collapse"> <ul class="nav navbar-nav navbar-right"> <li> <a class="page-scroll" title="Home" href="https://www.meetingsint.com/conferences/eye">Home</a> </li> <li> <a target="_blank" class="page-scroll" title="About" href="https://www.meetingsint.com/conferences/eye/about-us">About</a> </li> <li> <a target="_blank" class="page-scroll" title='Organizing Committee Members' href="https://www.meetingsint.com/conferences/eye/ocm">OCM</a> </li> <li class="dropdown show" onclick="myFunction()"> <a href="javascript:void(0);">Abstract<b class="caret"></b></a> <ul class="dropdown-menu" aria-labelledby="dropdownMenuLink" id="myLinks"> <li><a target="_blank" class="dropdown-item" title="Abstract Submission" href="https://www.meetingsint.com/conferences/eye/abstract-submission">Abstract Submission</a></li> <li><a target="_blank" class="dropdown-item" title="Call for Abstracts" href="https://www.meetingsint.com/conferences/eye/call-for-abstracts">Call for Abstracts</a></li> </ul> </li> <li> <a target="_blank" class="page-scroll" title="Conference Brochure" href="https://www.meetingsint.com/conferences/eye/conference-brochure">Brochure</a> </li> <li> <a target="_blank" class="page-scroll" title="Agenda" href="https://www.meetingsint.com/conferences/eye/scientific-program">Agenda</a> </li> <li> <a target="_blank" class="page-scroll" title="Sponsors" href="https://www.meetingsint.com/conferences/eye/sponsors">Sponsors</a> </li> <li> <a target="_blank" class="page-scroll" title="Venue" href="https://www.meetingsint.com/conferences/eye/venue-hospitality">Venue</a> </li> <li class="dropdown show" onclick="myFunctionOne()"> <a href="javascript:void(0);">Library <b class="caret"></b></a> <ul class="dropdown-menu" aria-labelledby="dropdownMenuLink" id="myLinksone"> <li><a target="_blank" class="dropdown-item" title="Young Scientist Award" href="https://www.meetingsint.com/conferences/eye/conference-young-scientist-award">YSA</a></li> <li><a target="_blank" class="dropdown-item" title="Advertisement" href="https://www.meetingsint.com/conferences/eye/advertisement">Advertisement</a></li> <li><a target="_blank" class="dropdown-item" title="Webinars" href="https://www.meetingsint.com/conferences/eye/webinars">Webinars</a></li> <li><a target="_blank" class="dropdown-item" title="Awards" href="https://www.meetingsint.com/conferences/eye/awards">Awards</a> </li> <li><a target="_blank" class="dropdown-item" title="E-Poster" href="https://www.meetingsint.com/conferences/eye/eposter">E-Poster</a> </li> </ul> </li> <li> <a target="_blank" class="page-scroll" title="Awards Nomination" href="https://www.meetingsint.com/conferences/eye/awards-nomination">Awards Nomination</a> </li> <li class="header-reg-btn"> <a class="btn btn-default my-btn btn-color ticket-btn" href="https://www.meetingsint.com/conferences/eye/registration" title="Registration">Registration</a> </li> </ul> </div> </div> </nav> </div> </header> <input type="hidden" value="https://www.meetingsint.com/conferences/eye" id="base_url"/> <div class="app_disp_styles" style="position: fixed; top: 130px;display:none;"> <div> <p>GET THE APP</p> </div> <a href="https://play.google.com/store/apps/details?id=com.applications.meetingsinternational" target="_blank" id=""> <div class="a_icon_android"> <span><i class="fa fa-android" aria-hidden="true"></i></span> </div> </a> </div>  <div class="inner-banner no-position"> <img src="https://www.meetingsint.com/assets/conf_web/images/inner-banner.jpg" alt="Inner Banner image"> <div class="on-banner-text"> <div class="header-banner"> <h1><span>Be a part of</span> <em> 12<sup>th</sup> International Conference on </em> Eye and Ophthalmology </h1> <h3> <span>About Us</span></h3> <div class="col-md-12 "> <a href="https://www.meetingsint.com/conferences/eye/advertisement" class="btn btn-default my-btn btn-color">Advertisement</a> </div> </div> </div> <section id="event-info" class="event-info"> <div class="container"> <div class="row"> <div class="col-sm-12 col-lg-4"> <div class="event-info-wrapper"> <div class="event-info-icon"> <i class="fa fa-calendar"></i> </div> <div class="event-info-content"> <h3 class="event-info-title">Date</h3> <div class="event-info-intro"><span>April 10-11, 2025</span> | 09:30 AM GMT</div> </div>  </div>  </div>  <div class="col-sm-6 col-lg-2"> <div class="event-info-wrapper"> <div class="event-info-icon"> <i class="fa fa-map-marker"></i> </div> <div class="event-info-content"> <h3 class="event-info-title">Location</h3> <p class="event-info-intro">Dubai, UAE</p> </div>  </div>  </div>  <div class="col-sm-6 col-lg-2"> <div class="event-info-wrapper"> <div class="event-info-icon"> <i class="fa fa-file-pdf-o"></i> </div> <div class="event-info-content"> <a href="https://www.meetingsint.com/conferences/eye/conference-brochure" title="Conference Brochure"> <h3 class="event-info-title">Download</h3> </a> <a href="https://www.meetingsint.com/conferences/eye/conference-brochure" title="Conference Brochure"> <p class="event-info-intro">Brochure</p> </a> </div>  </div>  </div>  <div class="col-sm-6 col-lg-2"> <div class="event-info-wrapper"> <div class="event-info-icon"> <i class="fa fa-cloud-upload"></i> </div> <div class="event-info-content"> <a href="https://www.meetingsint.com/conferences/eye/abstract-submission" title="Abstract Submission"> <h3 class="event-info-title">Submit</h3> <p class="event-info-intro">Abstract</p> </a> </div>  </div>  </div>  <div class="col-sm-6 col-lg-2"> <div class="event-info-wrapper"> <div class="event-info-icon"> <i class="fa fa-clock-o"></i> </div> <div class="event-info-content"> <a href="https://www.meetingsint.com/conferences/eye/scientific-pdf" title="Program Schedule"> <h3 class="event-info-title">Program</h3> <p class="event-info-intro">Schedule</p> </a> </div>  </div>  </div>  </div> </div> </section> </div> <div class="breadcrumbs-container"> <div class="container"> <ol class="breadcrumb"> <li><a href="https://www.meetingsint.com/conferences/eye" class="breadcrum_link">Home</a></li> <li class="active">About Us</li> </ol> </div> </div> <section class="sponsor-area" id="about"> <div id="float"></div> <div class="inner-content-container"> <div class="container"> <div class="row"> <div class="col-md-9 col-xs-12"> <div class="about-col ul-list"> <div class="panel-group" id="accordion"> <div class="panel panel-default"> <div class="panel-heading"> <h4 class="panel-title"> <a class="" data-parent="#accordion" href="#collapse0" data-toggle="collapse"> About Us </a> </h4> </div> <div id="collapse0" class="panel-collapse collapse in"> <div class="panel-body"> <div class=" mCustomScrollbar"><p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt">Welcome to the<strong> </strong></span><span style="font-size:12.0pt"><span style="background-color:white"><span style="color:#666666"><a href="https://www.meetingsint.com/conferences/eye/about-us">12th International Conference on Eye and Ophthalmology</a> </span></span></span><strong> </strong><span style="font-size:12.0pt">which is schedule to be<span style="color:#333333"> held on</span><strong> </strong><span style="background-color:white"><span style="color:#666666">April 10-11, 2025</span></span><strong> </strong><span style="color:#333333">in<strong> </strong></span><span style="background-color:white"><span style="color:#666666">Dubai, UAE. This year our theme is</span></span> “<strong>Shaping the Future of Ophthalmology with advancing technologies</strong><strong>”.</strong></span> <span style="font-size:12.0pt">At our ophthalmology conference<strong>, </strong>we are dedicated to advancing the field through collaboration, education, and innovation. We bring together leading experts, researchers, and practitioners to share the latest advancements, explore emerging technologies, and discuss cutting-edge treatments. Our goal is to foster a dynamic environment that inspires new ideas and drives progress in eye care. By participating in our conference, you join a community committed to enhancing vision and improving patient outcomes globally. Together, we are shaping the future of ophthalmology and paving the way for a brighter, clearer world.</span></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt">This conference offers a unique platform for networking, professional growth, and exchanging ideas that drive the field forward. We are thrilled to host this dynamic conference, dedicated to advancing the field of eye care through collaboration, education, and innovation. By participating in our conference, you join a community committed to enhancing vision and improving patient outcomes globally. Together, we are shaping the future of ophthalmology and paving the way for a brighter, clearer world.</span></span></span></p> </div> <br> <div class="mCustomScrollbar"> </div> </div> </div> </div> <div class="panel panel-default"> <div class="panel-heading"> <h4 class="panel-title"> <a class="collapsed" data-parent="#accordion" href="#collapse1" data-toggle="collapse"> Scientific Sessions </a> </h4> </div> <div id="collapse1" class="panel-collapse collapse "> <div class="panel-body"> <div class=" mCustomScrollbar"><div style="text-align:justify"><span style="font-size:14px"><span style="font-family:Arial,Helvetica,sans-serif"><strong>Session 1: <a href="https://www.meetingsint.com/conferences/eye/abstract-submission">Ophthalmology</a></strong> </span><br /> <span style="font-family:Arial,Helvetica,sans-serif">Ophthamology is the branch of medicine dedicated to the diagnosis, treatment, and prevention of eye diseases and disorders. It addresses various conditions including refractive errors, cataracts, glaucoma, macular degeneration, and diabetic retinopathy. Key diagnostic tools include visual acuity tests, slit-lamp exams, and tonometry. Treatments range from medications and laser therapy to surgery. Regular eye exams and management of chronic conditions are crucial for maintaining eye health.</span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="font-family:Arial,Helvetica,sans-serif"><a href="https://www.meetingsint.com/conferences/eye/conference-brochure">Ophthalmology conference</a> | <a href="https://www.meetingsint.com/conferences/eye/abstract-submission">Eye care congress</a> | <a href="https://www.meetingsint.com/conferences/eye/scientific-program">Eye health meetings</a></span></span></div> <div style="text-align:justify"><span style="font-size:14px"><strong>Related Societies:</strong><a href="https://www.meetingsint.com/conferences/eye/about-us"> American Academy of Ophthalmology (AAO)</a> |<a href="https://www.meetingsint.com/conferences/eye/call-for-abstracts"> American Association for Pediatric Ophthalmology and Strabismus (AAPOS) </a>|<a href="https://www.meetingsint.com/conferences/eye/ocm"> European Society of Ophthalmology (SOE)</a></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white"><strong><span style="background-color:white"><span style="color:#474747">Session 2: <a href="https://www.meetingsint.com/conferences/eye/registration">Ophthalmic and vision science</a></span></span></strong><a href="https://www.meetingsint.com/conferences/eye/registration"> </a></span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white"><span style="background-color:white"><span style="color:#202020">Ophthalmic and vision science is a multidisciplinary field </span></span><span style="color:#202020">centered</span><span style="background-color:white"><span style="color:#202020"> on understanding and </span></span><span style="color:#202020">progressing</span><span style="background-color:white"><span style="color:#202020"> eye </span></span><span style="color:#202020">wellbeing</span><span style="background-color:white"><span style="color:#202020"> and visual </span></span><span style="color:#202020">work</span>. It encompasses the study of eye anatomy, visual perception, and the mechanisms underlying various eye conditions and disorders. This field integrates clinical practices with scientific research to develop advanced diagnostic tools, treatments, and therapies. Key areas include the study of visual acuity, the impact of refractive errors, the development of interventions for eye diseases like glaucoma and macular degeneration, and innovations in corrective lenses and surgical techniques. The ultimate goal is to enhance vision quality and address visual impairments effectively.</span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white"><a href="https://www.meetingsint.com/conferences/eye/conference-brochure">Vision science conference</a> | <a href="https://www.meetingsint.com/conferences/eye/sponsors">Ophthalmic congress</a> | <a href="https://www.meetingsint.com/conferences/eye/venue-hospitality">Eye exam event</a></span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white"><strong> Related Societies:</strong> <a href="https://www.meetingsint.com/conferences/eye/abstract-submission">Association for Research in Vision and Ophthalmology (ARVO)</a> | <a href="https://www.meetingsint.com/conferences/eye/conference-brochure">Ophthalmic Research Society (ORS)</a><a href="https://www.meetingsint.com/conferences/eye/abstract-submission"> </a>| <a href="https://www.meetingsint.com/conferences/eye/about-us">International Society for Eye Research (ISER)</a></span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white"><strong><span style="color:#1e1e1e">Session 3:<a href="https://www.meetingsint.com/conferences/eye/registration"> Ocular oncology</a></span></strong><a href="https://www.meetingsint.com/conferences/eye/registration"> </a></span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white">Ocular oncology is a specialized branch of medicine dedicated to diagnosing and managing cancers and tumors of the eye. It addresses both primary eye tumors, such as retinoblastoma (common in children), melanoma of the uvea (including the iris, ciliary body, and choroid), and ocular surface tumors, as well as secondary tumors that spread to the eye from other parts of the body. Key diagnostic tools include imaging techniques like ultrasound, OCT, and MRI, along with biopsy when necessary. Treatments may involve surgery, radiation therapy, chemotherapy, or targeted therapies, depending on the tumor type and stage. The goal is to effectively manage or eliminate tumors while preserving vision and eye health.</span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white"><a href="https://www.meetingsint.com/conferences/eye/abstract-submission">Ocular oncology workshop</a> | <a href="https://www.meetingsint.com/conferences/eye/scientific-program">eye cancer conference</a> | <a href="https://www.meetingsint.com/conferences/eye/conference-brochure">chemotherapy events</a></span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white"><strong>Related Societies:</strong> <a href="https://www.meetingsint.com/conferences/eye/about-us">International Society of Ocular Oncology (ISOO) </a>| <a href="https://www.meetingsint.com/conferences/eye/conference-brochure">American Society of Retina Specialists (ASRS)</a> | <a href="https://www.meetingsint.com/conferences/eye/abstract-submission">European Society of Ophthalmic Oncology and Pathology (ESOPP)</a></span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white"><strong>Session 4:<a href="https://www.meetingsint.com/conferences/eye/abstract-submission"> Uveitis</a></strong><a href="https://www.meetingsint.com/conferences/eye/abstract-submission"> </a></span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white">Uveitis refers to the inflammation of the uvea, the middle layer of the eye comprising the iris, ciliary body, and choroid. It can be caused by infections, autoimmune diseases, or trauma, and may lead to symptoms such as eye pain, redness, blurred vision, and light sensitivity. Diagnosis typically involves a comprehensive eye exam and may include blood tests or imaging to identify the underlying cause. Treatment varies based on the cause and severity and often includes corticosteroids or other anti-inflammatory medications, as well as addressing any underlying conditions. Timely management is crucial to prevent complications like vision loss.</span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white"><span style="color:#080808"><a href="https://www.meetingsint.com/conferences/eye/awards-nomination">Uveitis congress</a> | <a href="https://www.meetingsint.com/conferences/eye/venue-hospitality">eye sessions </a>| <a href="https://www.meetingsint.com/conferences/eye/conference-brochure">diagnosis events</a></span></span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white"><strong><span style="color:#080808">Related Societies:</span></strong><a href="https://www.meetingsint.com/conferences/eye/abstract-submission"> American Uveitis Society (AUS)</a> | <a href="https://www.meetingsint.com/conferences/eye/abstract-submission">International Uveitis Study Group (IUSG)</a> | <a href="https://www.meetingsint.com/conferences/eye/advertisement">European Uveitis Society (EUS)</a></span></span></div> <div style="text-align:justify"><span style="font-size:14px"><strong>Session 5: <a href="https://www.meetingsint.com/conferences/eye/awards-nomination">Neuro-ophthalmology</a></strong><a href="https://www.meetingsint.com/conferences/eye/awards-nomination"> </a></span></div> <div style="text-align:justify"><span style="font-size:14px">Neuro-ophthalmology is a subspecialty that examines the intersection of the nervous system and eye disorders. It focuses on diagnosing and treating vision problems related to neurological conditions, such as optic neuritis, stroke, brain tumors, and nerve damage affecting eye movements. Key diagnostic methods include visual field testing, imaging studies like MRI and CT scans, and electrophysiological tests. Treatments may involve managing the underlying neurological condition and using interventions like medications or surgery to address specific eye symptoms. Effective neuro-ophthalmologic care is crucial for managing complex conditions where vision and neurological health intersect.</span></div> <div style="text-align:justify"><span style="font-size:14px"><a href="https://www.meetingsint.com/conferences/eye/registration">Neurologist workshops</a> |<a href="https://www.meetingsint.com/conferences/eye/advertisement"> ophthalmologist sessions</a> | <a href="https://www.meetingsint.com/conferences/eye/conference-brochure">neurology events</a></span></div> <div style="text-align:justify"><span style="font-size:14px"><strong>Related Societies:</strong> <a href="https://www.meetingsint.com/conferences/eye/conference-brochure">North American Neuro-Ophthalmology Society (NANOS)</a> | <a href="https://www.meetingsint.com/conferences/eye/abstract-submission">International Neuro-Ophthalmology Society (INOS)</a> | <a href="https://www.meetingsint.com/conferences/eye/abstract-submission">European Neuro-Ophthalmology Society (ENOS)</a></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:#f8f8f8"><strong>Session 6: <a href="https://www.meetingsint.com/conferences/eye/eposter">Oculoplastics</a></strong><a href="https://www.meetingsint.com/conferences/eye/eposter"> </a></span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:#f8f8f8"><span style="background-color:white"><span style="color:#202020">Oculoplastics is a subspecialty of ophthalmology </span></span><span style="color:#202020">centered</span><span style="background-color:white"><span style="color:#202020"> on the surgical and </span></span><span style="color:#202020">therapeutic</span> <span style="color:#202020">administration</span><span style="background-color:white"><span style="color:#202020"> of conditions </span></span><span style="color:#202020">influencing</span><span style="background-color:white"><span style="color:#202020"> the eyelids, tear </span></span><span style="color:#202020">channels</span><span style="background-color:white"><span style="color:#202020">, and </span></span><span style="color:#202020">circle</span><span style="background-color:white"><span style="color:#202020"> (the </span></span><span style="color:#202020">hard</span> <span style="color:#202020">depth</span><span style="background-color:white"><span style="color:#202020"> that houses the eye)</span></span>. It encompasses a range of procedures to correct functional and cosmetic issues, including eyelid surgery for drooping or misalignment, reconstruction following trauma or cancer, and treatment of tear duct blockages. Oculoplastic surgeons also address conditions such as ptosis (drooping eyelids), entropion (inward-turning eyelids), and ectropion (outward-turning eyelids.<span style="background-color:white"><span style="color:#202020"> This field combines </span></span><span style="color:#202020">tasteful</span><span style="background-color:white"><span style="color:#202020"> and reconstructive </span></span><span style="color:#202020">procedures</span><span style="background-color:white"><span style="color:#202020"> to </span></span><span style="color:#202020">make strides</span><span style="background-color:white"><span style="color:#202020"> both the appearance and </span></span><span style="color:#202020">work</span><span style="background-color:white"><span style="color:#202020"> of the eyes and </span></span><span style="color:#202020">encompassing</span><span style="background-color:white"><span style="color:#202020"> structures..</span></span></span></span></div> <div style="text-align:justify"><span style="font-size:14px"><a href="https://www.meetingsint.com/conferences/eye/registration">Eye Surgery conferences</a> | <a href="https://www.meetingsint.com/conferences/eye/awards">Ophthalmic Innovations events</a> | <a href="https://www.meetingsint.com/conferences/eye/awards-nomination">surgical techniques meetings</a></span></div> <div style="text-align:justify"><span style="font-size:14px"><strong>Related Societies:</strong> <a href="https://www.meetingsint.com/conferences/eye/advertisement">American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS)</a> |<a href="https://www.meetingsint.com/conferences/eye/abstract-submission"> European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS)</a> | <a href="https://www.meetingsint.com/conferences/eye/conference-brochure">International Society of Ocular Oncology (ISOO)</a></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white"><strong><span style="background-color:white"><span style="color:#1f1f1f"> Session 7:<a href="https://www.meetingsint.com/conferences/eye/scientific-program"> Glaucoma</a></span></span></strong><a href="https://www.meetingsint.com/conferences/eye/abstract-submission"> </a></span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white">Glaucoma is a group of eye diseases that damage the optic nerve, often due to increased intraocular pressure (IOP), leading to progressive vision loss and potentially blindness. The most common type is Primary Open-Angle Glaucoma, which develops slowly and without noticeable symptoms until significant vision loss occurs. Angle-Closure Glaucoma presents suddenly with severe symptoms like eye pain and blurred vision, requiring immediate treatment. Diagnosis involves measuring IOP, assessing the optic nerve, and conducting visual field tests. Treatment options include medications, laser therapy, and surgery to lower IOP and prevent further damage.</span></span></div> <div style="text-align:justify"><span style="font-size:14px"><a href="https://www.meetingsint.com/conferences/eye/conference-brochure">Glaucoma workshops</a> | <a href="https://www.meetingsint.com/conferences/eye/abstract-submission">Glaucoma Advances conferences</a> | <a href="https://www.meetingsint.com/conferences/eye/abstract-submission">eye diseases meetings </a></span></div> <div style="text-align:justify"><span style="font-size:14px"><strong>Related Societies:</strong><a href="https://www.meetingsint.com/conferences/eye/conference-brochure"> American Glaucoma Society (AGS)</a> | <a href="https://www.meetingsint.com/conferences/eye/venue-hospitality">International Society of Glaucoma Surgery (ISGS)</a> | <a href="https://www.meetingsint.com/conferences/eye/conference-young-scientist-award">E</a><a href="https://www.meetingsint.com/conferences/eye/sponsors">uropean Glaucoma Society (EGS)</a></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white"><strong><span style="background-color:white"><span style="color:#474747">Session 8: <a href="https://www.meetingsint.com/conferences/eye/conference-brochure">Cataracts</a></span></span></strong><a href="https://www.meetingsint.com/conferences/eye/eposter"> </a></span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white"><span style="background-color:white"><span style="color:#202020">Cataracts are a common eye condition where the </span></span><span style="color:#202020">focal point</span><span style="background-color:white"><span style="color:#202020"> of the eye </span></span><span style="color:#202020">gets to be</span><span style="background-color:white"><span style="color:#202020"> cloudy, </span></span><span style="color:#202020">driving</span><span style="background-color:white"><span style="color:#202020"> to </span></span><span style="color:#202020">obscured</span><span style="background-color:white"><span style="color:#202020"> vision and visual </span></span><span style="color:#202020">impedance</span><span style="background-color:white"><span style="color:#202020">. </span></span>They develop gradually, often due to aging, but can also result from injury, certain medications, or underlying health conditions like diabetes. Symptoms are like feeling difficult to see at night, sensitivity to light and faded colors. Diagnosis is made through a comprehensive eye exam, including visual acuity testing and examination of the lens. Treatment involves cataract surgery, where the cloudy lens is replaced with a clear artificial lens, effectively restoring vision. Cataract surgery is generally safe and highly effective, with most patients experiencing significant improvement in vision.</span></span></div> <div style="text-align:justify"><span style="font-size:14px"><a href="https://www.meetingsint.com/conferences/eye/conference-brochure"><strong><span style="background-color:white"><span style="color:#1f1f1f"> Refractive surgery</span></span></strong></a></span></div> <div style="text-align:justify"><span style="font-size:14px">is a set of procedures aimed at correcting vision problems by altering the shape of the cornea to improve light focus on the retina. The most common types are:</span></div> <div style="text-align:justify"><span style="font-size:14px">LASIK (Laser-Assisted In Situ Keratomileusis),LASEK (Laser-Assisted Subepithelial Keratectomy),PRK (Photorefractive Keratectomy.</span></div> <div style="text-align:justify"><span style="font-size:14px">The refractive surgery market is poised for continued growth driven by technological advancements, increasing patient awareness, and a rising prevalence of vision disorders.</span></div> <div style="text-align:justify"><span style="font-size:14px"><a href="https://www.meetingsint.com/conferences/eye/awards">LASIK workshops</a><a href="https://www.meetingsint.com/conferences/eye/abstract-submission"> | </a><a href="https://www.meetingsint.com/conferences/eye/advertisement">Retina surgery congress</a><a href="https://www.meetingsint.com/conferences/eye/abstract-submission"> | </a><a href="https://www.meetingsint.com/conferences/eye/conference-young-scientist-award">Retinal research events</a></span></div> <div style="text-align:justify"><span style="font-size:14px"><strong>Related Societies:</strong><a href="https://www.meetingsint.com/conferences/eye/abstract-submission"><strong> </strong></a><a href="https://www.meetingsint.com/conferences/eye/sponsors">American Society of Cataract and Refractive Surgery (ASCRS)</a><a href="https://www.meetingsint.com/conferences/eye/abstract-submission">| </a><a href="https://www.meetingsint.com/conferences/eye/venue-hospitality">European Society of Cataract and Refractive Surgeons (ESCRS) </a><a href="https://www.meetingsint.com/conferences/eye/abstract-submission">| International Society of Refractive Surgery (ISRS)</a></span></div> <div style="text-align:justify"><span style="font-size:14px"><strong>Session 9: <a href="https://www.meetingsint.com/conferences/eye/awards">Artificial Intelligence (AI) in ophthalmology</a></strong><a href="https://www.meetingsint.com/conferences/eye/awards"> </a></span></div> <div style="text-align:justify"><span style="font-size:14px">Artificial Intelligence (AI) in ophthalmology<strong> </strong>involves using advanced algorithms and machine learning to enhance eye care. AI applications include:</span></div> <div style="text-align:justify"><span style="font-size:14px">Disease Detection,Diagnostic Assistance,Surgical Planning.</span></div> <div style="text-align:justify"><span style="font-size:14px">.AI enhances early detection, precision, and efficiency in ophthalmic care, potentially improving patient outcomes and reducing the burden on healthcare systems.</span></div> <div style="text-align:justify"><span style="font-size:14px"><a href="https://www.meetingsint.com/conferences/eye/awards">Advanced Imaging Techniques symposiums</a> | <a href="https://www.meetingsint.com/conferences/eye/venue-hospitality">Telemedicine in Eye Care workshops</a> |<a href="https://www.meetingsint.com/conferences/eye/conference-brochure"> Laser treatment events</a></span></div> <div style="text-align:justify"><span style="font-size:14px"><strong>Related Societies:</strong> <a href="https://www.meetingsint.com/conferences/eye/abstract-submission">IEEE Engineering in Medicine and Biology Society (EMBS)</a> | <a href="https://www.meetingsint.com/conferences/eye/about-us">The Vision AI Network</a><a href="https://www.meetingsint.com/conferences/eye/venue-hospitality"> | European Association for Vision and Eye Research (EVER)</a></span></div> <div style="text-align:justify"><span style="font-size:14px"><strong><span style="background-color:white"><span style="color:#1f1f1f">Session 10: </span><a href="https://www.meetingsint.com/conferences/eye/about-us"><span style="color:#202020">Pediatric </span><span style="color:#1f1f1f">Ophthalmology</span></a></span></strong> </span></div> <div style="text-align:justify"><span style="font-size:14px"> Pediatric ophthalmologyis centered on diagnosing, treating, and managing eye conditions in children. Key areas include:</span></div> <ul> <li style="text-align:justify"> <div><span style="font-size:14px">Common Conditions: Strabismus (eye misalignment), amblyopia (lazy eye), congenital cataracts, and refractive errors such as myopia, hyperopia, and astigmatism.</span></div> </li> <li style="text-align:justify"> <div><span style="font-size:14px">Diagnostic Techniques: Comprehensive eye exams, including visual acuity tests, eye muscle assessments, and imaging if needed.</span></div> </li> <li style="text-align:justify"> <div><span style="font-size:14px">Treatment Options: May include corrective lenses, patching therapy for amblyopia, surgical interventions for strabismus or cataracts, and management of genetic or developmental eye conditions.<span style="background-color:white"><span style="color:#202020">Early </span></span><span style="color:#202020">discovery</span><span style="background-color:white"><span style="color:#202020"> and </span></span><span style="color:#202020">mediation</span><span style="background-color:white"><span style="color:#202020"> are </span></span><span style="color:#202020">basic</span><span style="background-color:white"><span style="color:#202020"> in pediatric ophthalmology to </span></span><span style="color:#202020">bolster</span> <span style="color:#202020">sound</span><span style="background-color:white"><span style="color:#202020"> visual </span></span><span style="color:#202020">improvement</span><span style="background-color:white"><span style="color:#202020"> and </span></span><span style="color:#202020">deflect</span><span style="background-color:white"><span style="color:#202020"> long-term vision issues.</span></span></span></div> </li> </ul> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white"><span style="color:#202020"><a href="https://www.meetingsint.com/conferences/eye/abstract-submission">Pediatric conference</a> | </span></span><a href="https://www.meetingsint.com/conferences/eye/abstract-submission">Advanced Diagnostic Tools workshops</a> | <a href="https://www.meetingsint.com/conferences/eye/abstract-submission">Public health workshops</a></span></div> <div style="text-align:justify"><span style="font-size:14px"><strong>Related Societies: </strong><a href="https://www.meetingsint.com/conferences/eye/awards-nomination">American Association for Pediatric Ophthalmology and Strabismus (AAPOS)</a> |<a href="https://www.meetingsint.com/conferences/eye/advertisement"> European Society of Pediatric Ophthalmology (ESPO)</a> | <a href="https://www.meetingsint.com/conferences/eye/venue-hospitality">International Society of Pediatric Ophthalmology and Strabismus (ISPOS)</a></span></div> <div style="text-align:justify"><span style="font-size:14px"><strong>Session 11: <a href="https://www.meetingsint.com/conferences/eye/conference-young-scientist-award">Genetic Disorders</a></strong><a href="https://www.meetingsint.com/conferences/eye/conference-young-scientist-award"> </a></span></div> <div style="text-align:justify"><span style="font-size:14px">Genetic disorders of the eye involve inherited conditions that affect vision and eye structure. Key examples include:</span></div> <div style="text-align:justify"><span style="font-size:14px">Retinitis Pigmentosa (RP),Leber Congenital Amaurosis (LCA),Stargardt Disease,Usher Syndrome,Marfan Syndrome,Aniridia</span></div> <div style="text-align:justify"><span style="font-size:14px">These conditions often require genetic testing for diagnosis, and management may involve regular monitoring, vision aids, and sometimes experimental treatments or gene therapy. Early diagnosis and intervention are essential to managing symptoms and preserving vision.The market for genetic disorders in ophthalmology is evolving rapidly due to technological advancements, increasing awareness, and investment in research and development.</span></div> <div style="text-align:justify"><span style="font-size:14px"><a href="https://www.meetingsint.com/conferences/eye/about-us">Genetic Eye Disorders congress</a> |<a href="https://www.meetingsint.com/conferences/eye/awards-nomination"> Age-related Macular Degeneration (AMD) events</a> | <a href="https://www.meetingsint.com/conferences/eye/venue-hospitality">Genetic disorder conference</a></span></div> <div style="text-align:justify"><span style="font-size:14px"><strong>Related Societies:</strong><a href="https://www.meetingsint.com/conferences/eye/advertisement"> Genetics Society</a> | <a href="https://www.meetingsint.com/conferences/eye/venue-hospitality">American Society of Human Genetics (ASHG) </a>| <a href="https://www.meetingsint.com/conferences/eye/registration">National Society of Genetic Counselors (NSGC)</a></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:#f8f8f8"><strong><span style="background-color:white"><span style="color:#1f1f1f">Session 12: <a href="https://www.meetingsint.com/conferences/eye/eposter">Keratoprosthesis</a></span></span></strong><a href="https://www.meetingsint.com/conferences/eye/eposter"> </a></span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:#f8f8f8">Keratoprosthesis is a surgical procedure involving the implantation of an artificial cornea to restore vision in patients with severe corneal damage or blindness where traditional corneal transplantation is not feasible. It is typically used in cases of end-stage corneal disease, severe corneal scarring, or failed corneal transplants. The procedure involves inserting a synthetic lens into the eye to replace the damaged cornea. Keratoprosthesis can significantly improve vision and quality of life, but it carries risks such as infection, graft rejection, and complications related to the artificial device. Long-term follow-up is essential for managing potential complications and ensuring optimal outcomes.</span></span></div> <div style="text-align:justify"><span style="font-size:14px"><a href="https://www.meetingsint.com/conferences/eye/awards">Corneal Health workshps</a> |<a href="https://www.meetingsint.com/conferences/eye/awards-nomination"> Digital Health Solutions meetings</a> |<a href="https://www.meetingsint.com/conferences/eye/conference-young-scientist-award"> organ transplantation events</a></span></div> <div style="text-align:justify"><span style="font-size:14px"><strong>Related Societies: </strong><a href="https://www.meetingsint.com/conferences/eye/conference-young-scientist-award">Cornea Society</a> |<a href="https://www.meetingsint.com/conferences/eye/abstract-submission"> American Academy of Ophthalmology (AAO)</a> | <a href="https://www.meetingsint.com/conferences/eye/abstract-submission">European Cornea Society (EuCornea)</a></span></div> <div style="text-align:justify"> </div> <div style="text-align:justify"> </div> <div style="text-align:justify"> </div> </div> <br> </div> </div> </div> <div class="panel panel-default"> <div class="panel-heading"> <h4 class="panel-title"> <a class="collapsed" data-parent="#accordion" href="#collapse2" data-toggle="collapse"> Market Analysis </a> </h4> </div> <div id="collapse2" class="panel-collapse collapse "> <div class="panel-body"> <div class=" mCustomScrollbar"><p style="text-align:justify"><span style="font-size:12pt"><span style="background-color:white"><span style="color:#13293d">One of the primary factors driving the growth of the ophthalmology market is the rising prevalence of ophthalmic disorders & ocular pains. The continuing clinical trial research being conducted by several pharmaceutical businesses to better treatment choices and exposure to certain toxins or environmental changes increase the occurrence of ophthalmology products and leads to market expansion. The market is also influenced by increased unhygienic & sedentary lifestyles and a rise in traumatic injuries. However, high cost & risks associated with eye surgery & treatment, lack of health insurance amongst the population, especially within developing countries, and prolonged-time period for manufacturing & formulating ophthalmic drugs acts as restraining factor for the global ophthalmology market in the forecast period.</span></span></span></p> <p> </p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><img alt="Ophthalmology Market Size 2023 To 2032" src="data:image/jpeg;base64,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" style="height:369px; width:624px" /></span></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong><span style="font-size:12.0pt"><span style="background-color:white"><span style="color:#212529">The global ophthalmology market size reached USD 7.97 billion in 2023 and is expected to hit around USD 22.68 billion by 2032, poised to grow at a CAGR of 12.32% during the forecast period from 2023 to 2032.</span></span></span></strong></span></span></p> <p> </p> </div> <br> </div> </div> </div> <div class="panel panel-default"> <div class="panel-heading"> <h4 class="panel-title"> <a class="collapsed" data-parent="#accordion" href="#collapse3" data-toggle="collapse"> Young Research Forum </a> </h4> </div> <div id="collapse3" class="panel-collapse collapse "> <div class="panel-body"> <div class=" mCustomScrollbar"><p style="text-align:justify"><span style="font-size:11pt"><span style="background-color:white"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background-color:white"><span style="color:#656565">The </span></span></span><span style="font-size:12.0pt"><a href="https://www.meetingsint.com/conferences/eye/awards-nomination">Young Research Forum</a><span style="background-color:white"><span style="color:#656565"> at the Ophthalmology 2025 Conference is a platform dedicated to fostering the development and nurturing of the talent of young opthalmologists and researchers. This forum aims to provide a unique space for young professionals to exchange ideas, showcase their research, and engage in meaningful discussions with peers and established experts in the field of Ophthalmology. The content for this forum is carefully curated to address emerging trends, breakthroughs, and challenges in ophthalmology, with a focus on encouraging innovative thinking and collaboration among the next generation of researchers.</span></span><br /> <span style="color:#656565"><span style="background-color:white">The content outlined for the Young Research Forum at the </span></span><a href="https://www.meetingsint.com/conferences/eye/awards">Ophthalmology 2025 conference</a><span style="background-color:white"><span style="color:#656565"> embodies the spirit of innovation and collaboration that is crucial for advancing the field of vision care. By addressing a diverse range of topics, from cutting-edge treatment modalities to ground breaking research methodologies, this forum aims to inspire and empower the next generation of Ophthalmologist, ensuring a brighter future for health care worldwide.</span></span></span></span></span></span></p> </div> <br> </div> </div> </div> <div class="panel panel-default"> <div class="panel-heading"> <h4 class="panel-title"> <a class="collapsed" data-parent="#accordion" href="#collapse4" data-toggle="collapse"> Advertisement </a> </h4> </div> <div id="collapse4" class="panel-collapse collapse "> <div class="panel-body"> <div class=" mCustomScrollbar"><div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white"><span style="font-family:Calibri,sans-serif"><span style="color:#656565">Meetings Int. is a worldwide pioneer in delivering top-notch gatherings, workshops, and symposia in every significant field of science, innovation, and medication worldwide receiving 400,000+ online visitors with 1000+ sessions which confirms an outstanding pool of new users and visitors creating a platform to build your market place globally. Since its initiation, Meetings Int. has been related to national and global affiliations, organizations, and elevated-level people, committed to having world-class meetings and occasions so it provides a big platform to show your product and advertising. The Explorer’s traffic is the benchmark for advertisement, and the Ophthalmology Conference website is continually dragged worldwide. As specified by Google Analytics, in excess of 12,836 researchers and industrials are visiting our conference sites. <a href="https://www.meetingsint.com/conferences/eye/advertisement">Eye and ophthalmology 2025</a> seminar helps you put the spotlight on your brand by advertising with more than 9 million+ readers worldwide about 5 million+ hits every month on our site. We provide an excellent opportunity to boost your business on our platform. We offer a range of eye-catching advertising spaces and branding. Researchers from powerful nations including the United States, Japan, United Kingdom, India, France, Taiwan, and Germany, etc.  Visit our conference site. Subscribers and conference attendees can be your upcoming enthusiastic customers. We maintain high quality and ethical standards in the event industry, which makes us unique and better than the rest. Advertisement banners must be provided by the advertising company and in jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.</span></span></span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white"><span style="font-family:Calibri,sans-serif"><span style="color:#656565">You can also Contact us:</span></span></span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="background-color:white"><span style="font-family:Calibri,sans-serif"><span style="color:#656565">Contact person: Valentina Ward</span></span></span></span></div> <div style="text-align:justify"><span style="font-size:14px"><span style="font-family:Calibri,sans-serif"> <span style="color:#656565">Contact Email: </span></span>contact@meetingsint.com</span></div> <p> </p> </div> <br> </div> </div> </div> </div> </div> </div> <div class="col-md-3 column col-xs-12"> <div class="nav-section" id="styledDiv"> <div class="sidebar sidebar-right"> <div class="theiaStickySidebar inner-content-container"> <div class="sidebar sidebar-right"> <div class="widget recent-posts"> <h3 class="widget-title">Recommended Conferences</h3> <ul class="unstyled clearfix"> <li> <div class="post-info-custom" style="top: 50% !important;"> <h4 class="entry-title" style="color:#00b4ff;text-transform: capitalize;"> Upcoming Conferences will be updated soon ... </h4> </div> <div class="clearfix"></div> </li> </ul> </div> </div> </div> </div> </div>  <script type="text/javascript"> $(window).scroll(function() { var wS = $(this).scrollTop(); if(($('#styledDiv').length) && ($('#float').length) && ($('#float_bottom').length) ){ var styledDiv = $('#styledDiv'), targetScroll = $('#float').offset().top, finalscroll = $('#float_bottom').offset().top, fH = $('#float_bottom').outerHeight(), wH = $(window).height(); var currentScroll = $('html').scrollTop() || $('body').scrollTop(); styledDiv.toggleClass('fixedPos', wS >= targetScroll); styledDiv.toggleClass('absolutePos', wS >= (finalscroll+fH-wH)); } }); </script> </div> </div> </div> </div> </section> <section class="counter-area parallax"> <div id="float_bottom"></div> <div class="container"> <div class="center"> <div class="col-md-3 col-sm-6 col-xs-6 fw-600"> <div class="counter-col"> <div class="icon"> <img loading="lazy" src="https://www.meetingsint.com/assets/conf_web/images/icon-1.png"> </div> <p>Meet Experts</p> </div> </div> <div class="col-md-3 col-sm-6 col-xs-6 fw-600"> <div class="counter-col"> <div class="icon"> <img loading="lazy" src="https://www.meetingsint.com/assets/conf_web/images/icon-2.png"> </div> <p>Global Networking</p> </div> </div> <div class="col-md-3 col-sm-6 col-xs-6 fw-600"> <div class="counter-col"> <div class="icon"> <img loading="lazy" src="https://www.meetingsint.com/assets/conf_web/images/icon-3.png"> </div> <p>Learning In a New Space</p> </div> </div> <div class="col-md-3 col-sm-6 col-xs-6 fw-600"> <div class="counter-col"> <div class="icon"> <img loading="lazy" src="https://www.meetingsint.com/assets/conf_web/images/icon-4.png"> </div> <p>New Tips & Tactics</p> </div> </div> <div class="col-md-3 col-sm-6 col-xs-6 fw-600"> <div class="counter-col"> <div class="icon rotate"> <img loading="lazy"src="https://www.meetingsint.com/assets/conf_web/images/icon-5.png"> </div> <p>Certification</p> </div> </div> </div> </div> </section><section class="sponsor-area" id="supporters"> <div class="inner-content-container"> <div class="container"> <div class="row"> <div class="col-md-8 col-md-offset-2 col-xs-12"> <div class="section-title"> <h2>Our <span>Supporters</span></h2> </div> </div> </div> <div class="row"> <div class="col-md-2 col-xs-12"> <div class="sponsor-col"> <a href="https://www.meetingsint.com/conferences/eye/supporters" title="Media Partners"> <img loading="lazy" src="https://d2cax41o7ahm5l.cloudfront.net/mi/upload-images/eye@2025-53654.jpg" alt="" title="Media Partners" style="width:165px;height:74px;" /></a> </div> </div><div class="col-md-2 col-xs-12"> <div class="sponsor-col"> <a href="https://www.meetingsint.com/conferences/eye/supporters" title="Media Partners"> <img loading="lazy" src="https://d2cax41o7ahm5l.cloudfront.net/mi/upload-images/eye@2025-85655.jpg" alt="" title="Media Partners" style="width:165px;height:74px;" /></a> </div> </div><div class="col-md-2 col-xs-12"> <div class="sponsor-col"> <a href="https://www.meetingsint.com/conferences/eye/supporters" title="Media Partners"> <img loading="lazy" src="https://d2cax41o7ahm5l.cloudfront.net/mi/upload-images/eye@2025-78257.png" alt="" title="Media Partners" style="width:165px;height:74px;" /></a> </div> </div> </div> </div> </div> </section> <style> .hi-icon-effect-4 .hi-icon svg{ width: 15px; margin-top: 9px; } </style>  <footer class="footer-area"> <div class="container"> <div class="row"> <div class="col-center"> <div class="col-md-6 col-lg-6 col-xs-12"> </div> </div> <div class="col-md-12"> <div class="footer-col hi-icon-wrap hi-icon-effect-4 hi-icon-effect-4b"> <a href="https://www.facebook.com/MeetingsIntl/" class="hi-icon"> <i class="fa fa-facebook" aria-hidden="true"></i> </a> <a href="https://twitter.com/MeetingsInt" class="hi-icon"> <svg id="Capa_1" enable-background="new 0 0 1226.37 1226.37" viewBox="0 0 1226.37 1226.37" xmlns="http://www.w3.org/2000/svg"> <path fill="#ffffff" d="m727.348 519.284 446.727-519.284h-105.86l-387.893 450.887-309.809-450.887h-357.328l468.492 681.821-468.492 544.549h105.866l409.625-476.152 327.181 476.152h357.328l-485.863-707.086zm-144.998 168.544-47.468-67.894-377.686-540.24h162.604l304.797 435.991 47.468 67.894 396.2 566.721h-162.604l-323.311-462.446z" /> <g /> <g /> <g /> <g /> <g /> <g /> <g /> <g /> <g /> <g /> <g /> <g /> <g /> <g /> <g /> </svg> </a> <a href="https://www.linkedin.com/company/meetingsint/" class="hi-icon"> <i class="fa fa-linkedin" aria-hidden="true"></i> </a> <a href="https://www.flickr.com/photos/meetingsint/" class="hi-icon"> <i class="fa fa-flickr" aria-hidden="true"></i> </a> <a href="https://www.youtube.com/c/MeetingsInternational" class="hi-icon"> <i class="fa fa-youtube" aria-hidden="true"></i> </a> <a href="https://plus.google.com/u/0/+MeetingsInt" class="hi-icon"> <i class="fa fa-google-plus" aria-hidden="true"></i> </a> </div> </div> <style type="text/css"> .bell_icon { position: fixed; right: 0px; z-index: 99999; /*top: 85px; width: auto !important;*/ bottom: 80px; } .quick-links a.bell_icon:before { display:none; } .bell_icon img { max-width: 150px; } .conf_unique_email4{ width:auto !important; } @media(max-width:568px){ /*.bell_icon { position: fixed; right: 0px; z-index: 99999; top: inherit; width: auto !important; bottom: -15px; }*/ .bell_icon img { max-width: 120px; } } </style> <a href="https://www.globaltechsummit.com/" class="bell_icon" target="_blank" style="display:none;"><img src="https://www.vizagtechsummit.com/images/bellicon.png"></a> <div class="col-md-12 foot-link col-xs-12 col-lg-12"> <ul> <li><a href="https://www.meetingsint.com/conferences/eye/about-us" title="About">About</a></li> <li><a href="https://www.meetingsint.com/contact-us" title="Contact Us">Contact Us</a></li> <li><a href="https://www.meetingsint.com/conferences/eye/faq" title="FAQs">FAQs</a></li> <li><a href="https://www.meetingsint.com/conferences/eye/terms-and-condition" title="Terms & Conditions">Terms and Conditions</a></li> <li><a href="https://www.meetingsint.com/conferences/eye/privacy-policy" title="Privacy Policy">Privacy Policy</a></li> </ul> </div> </div> </div>  <button type="button" class="btn btn-primary btn-lg view-links" data-toggle="modal" data-target="#myModal" title="Reach Us Through"> <span class="glyphicon glyphicon-envelope" aria-hidden="true"></span> </button>  <div class="modal fade" id="myModal" tabindex="-1" role="dialog" aria-labelledby="myModalLabel"> <div class="modal-dialog" role="document"> <div class="modal-content"> <div class="modal-body"> <div id="feedback" style="display:inline-block;"> <div class="col-xs-6"> <i class="fa fa-envelope" aria-hidden="true"></i> <a href="mailto:abstracts@meetingsint.com" title="Abstracts enquiry">abstracts@meetingsint.com</a> </div> <div class="col-xs-6"> <i class="fa fa-envelope" aria-hidden="true"></i> <a href="mailto:finance@meetingsint.com" title="Finance enquiry">finance@meetingsint.com</a> </div> <div class="col-xs-6"> <i class="fa fa-envelope" aria-hidden="true"></i> <a href="mailto:contact@meetingsint.com" title="Contact Enquiry">contact@meetingsint.com</a> </div> </div> </div> <div class="modal-footer"> <button type="button" class="btn btn-default" data-dismiss="modal">Close</button> </div> </div> </div> </div> <div class="conf_unique_email conf_unique_email4"> <a target="_blank" href="https://www.meetingsint.com/speakers-interview" title="Speakers Interview">Speakers Interview</a> </div> <style type="text/css"> .btn.view-links{ position: fixed; right: 0; bottom: 170px; background: #d37d17; } .btn.view-links .glyphicon.glyphicon-envelope{ font-size:24px; } .conf_unique_email4{ background:#d32f2f; } </style> <style type="text/css"> sikicem { display: none; }</style><sikicem>Kendisini odas谋na kapat谋p sadece v眉cut 莽al谋艧an 眉vey o臒lunun <a href="https://www.sexrosa.com" title="rokettube">rokettube</a> adeta tavan yapan hormonlar谋n谋 aktif hale getirmek i莽in kal莽alar谋n谋 ve <a href="https://www.carmelporno.com" title="porno">porno</a> memelerini 枚n plana 莽谋kartan olgun 眉vey anne gen莽 erke臒i kolayl谋kla zevk <a href="https://www.sexlora.com" title="porno izle">porno izle</a> tuza臒谋na d眉艧眉r眉r aylard谋r 莽ekti臒i yaraks谋zl谋臒谋n y谋lba艧谋 gecesinde <a href="https://www.halleporno.com" title="xhamster">xhamster</a> son bulmas谋 i莽in iyi dilekler dileyen seksi 眉vey ablas谋n谋 duyarak gece yar谋s谋ndan <a href="https://www.sexmercy.com" title="sex izle">sex izle</a> sonra 莽谋r谋l莽谋plak bir 艧ekilde kar艧谋s谋na 莽谋kan sert adam b眉y眉k yara臒谋 <a href="https://www.pornojan.com" title="altyaz谋l谋 porno">altyaz谋l谋 porno</a> g枚ren hatunu an谋nda etkisi alt谋na al谋r i艧taha gelen g枚z眉 d枚nm眉艧 hatunun soyunarak <a href="https://www.sexlexi.com" title="siki艧">siki艧</a> alete sald谋rmas谋yla dakikalar i莽erisinde kaskat谋 kesilen gen莽 adam 眉vey ablas谋n谋 <a href="https://www.sexleila.com" title="brazzers">brazzers</a> alt谋na al谋p evire 莽evire sikerek ilk kez bu kadar b眉y眉k bir aleti tatmas谋n谋 sa臒lar <a href="https://www.letaporn.com" title="xnxx">xnxx</a> ard谋ndan s谋ms谋k谋 yara臒谋 a臒z谋nda ve memelerinin aras谋nda gezdirip cay谋r cay谋r yanan p眉r眉zs眉z <a href="https://www.pornorina.com" title="altyaz谋l谋 porno">altyaz谋l谋 porno</a> amc谋臒谋na almak i莽in pozisyona giren s眉rt眉k azman 眉vey o臒luna <a href="https://www.sekshero.com" title="seks izle">seks izle</a> nefes kesen dakikalar ya艧atarak rahatlamas谋na yard谋mc谋 olur</sikicem></footer> <section class="footer-copy-right text-white"> <div class="container"> <div class="row"> <div class="col-md-12 text-center col-xs-12 col-lg-12"> <p>漏 2024-2016 Meetings International. All Rights Reserved</p> </div> </div> </div> </section> <script src="https://www.meetingsint.com/assets/conf_web/js/bootstrap.min.js" defer></script> <script src="https://www.meetingsint.com/assets/conf_web/js/mixed.js" defer></script> <script> window.ga=window.ga||function(){(ga.q=ga.q||[]).push(arguments)};ga.l=+new Date; ga('create','UA-112094404-1','auto'); ga('require','ecommerce'); ga('send','event'); ga('send','pageview'); ga('send','social'); </script> <script async src='https://www.google-analytics.com/analytics.js'></script> <script type="application/ld+json"> { "@context": "https://schema.org", "@type": "Event", "name": "About", "startDate": "2025-04-10", "endDate": "2025-04-11", "eventAttendanceMode": "https://schema.org/MixedEventAttendanceMode", "eventStatus": "https://schema.org/EventScheduled", "location": [ { "@type": "VirtualLocation", "url": "https://www.meetingsint.com/conferences/eye" }, { "@type": "Place", "name": "Dubai, UAE", "address": { "@type": "PostalAddress", "streetAddress": "28 Maxwell Road, #03-05 Red Dot Traffic", "addressLocality": "Singapore", "postalCode": "069120", "addressRegion": "Singapore", "addressCountry": "Singapore" } } ], "image": [ "https://d2cax41o7ahm5l.cloudfront.net/mi/new-assets/images/logos/meetings-international.png" ], "description": "Connect with Experts and Global Performers at Ophthalmology 2025 conference Join us for insightful discussions impactful presentations and networking opportunities that shape the future of oncology ", "offers": { "@type": "Offer", "url": "https://www.meetingsint.com/conferences/eye/registration", "price": "100", "priceCurrency": "USD", "availability": "https://schema.org/InStock", "validFrom": "2024-11-30" }, "performer": { "@type": "PerformingGroup", "name": "Speakers from Ophthalmology" }, "organizer": { "@type": "Organization", "name": "Meetings International", "url": "https://www.meetingsint.com" } } </script> <script type='application/ld+json'> { "@context": "http://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "item": { "@id": "https://www.meetingsint.com/", "name": "Meetings International" } }, { "@type": "ListItem", "position": 2, "item": { "@id": "https://www.meetingsint.com/conferences/", "name": "Ophthalmology Conferences" } }, { "@type": "ListItem", "position": 3, "item": { "@id": "https://www.meetingsint.com/conferences/eye", "name": "Eye and Vision 2025 Conferences" } } ] } </script>  <script type="text/javascript"> var Tawk_API=Tawk_API||{}, Tawk_LoadStart=new Date(); (function(){ var s1=document.createElement("script"),s0=document.getElementsByTagName("script")[0]; s1.async=true; s1.src='https://embed.tawk.to/66fd2e34e5982d6c7bb7959a/1i96fovon'; s1.charset='UTF-8'; s1.setAttribute('crossorigin','*'); s0.parentNode.insertBefore(s1,s0); })(); </script> </body> </html>